Skip to content

Balloon cryoablation catheter in the field of atrial fibrillation application demonstration

Balloon cryoablation catheter in the field of atrial fibrillation application demonstration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102205
Enrollment
Unknown
Registered
2025-05-12
Start date
2025-05-12
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal atrial fibrillation

Interventions

Single unit:Cryoablation

Sponsors

Zhongshan Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years old, regardless of gender; 2. The patient was clinically diagnosed as paroxysmal atrial fibrillation. 3. The patient is willing to evaluate the clinical protocol requirements; 4. Prior to treatment, subjects (or their guardians) agreed to participate in the study and signed an EC-approved informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone left atrial appendage closure; 2. Patients who had undergone left atrial ablation or left atrial surgery in the past; 3. Patients who have undergone valve repair; 4. Severe organic heart disease, including rheumatic heart disease, hypertrophic cardiomyopathy, dilated cardiomyopathy, etc; 5. Have a history of anticoagulant contraindications or bleeding disease within 6 months; 6. Patients with thrombus in left atrial/left auricle before operation; 7. Echocardiography showed that the anterior and posterior diameter of the left atrium was >=50mm; 8. LVEF(%) is less than 40%; 9. Patients fitted with one or more pulmonary vein stents; 10. The patient had undergone atrial septal repair or other surgical procedures in or near the atrial septum; 11. Other conditions assessed by the investigators as unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Treatment success rate 12 months after operation;To study the incidence of device-related adverse events;

Secondary

MeasureTime frame
Immediate surgical success rate;Therapeutic effectiveness;Number of cryoablation/pulmonary veins;Cryoablation time;Instrument performance evaluation;Incidence of complications;

Countries

China

Contacts

Public ContactNie Zhenning

Zhongshan Hospital Affiliated to Fudan University

nie.zhenning@zs-hospital.sh.cn+86 136 8197 3682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026